The underlying molecular mechanisms of Fyn in neonatal hypoxic-ischaemic encephalopathy

Jiao Zhou1,2, Xiang Lu3, Haichuan Wang4

  • 1Department of Reproductive Medicine Nursing, West China Second University Hospital, Sichuan University, Chengdu, China.

PubMed

Insights

Fyn kinase plays a key role in neonatal hypoxic-ischaemic encephalopathy (HIE) by influencing excitotoxicity and neuroinflammation. Understanding Fyn

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Biochemistry

Background:

  • Fyn is a cytoplasmic tyrosine kinase (TK) and a member of the Src family of kinases (SFKs).
  • Fyn is implicated in crucial central nervous system (CNS) processes including oligodendrocyte development, myelination, axon guidance, and synaptic transmission.
  • Its involvement in molecular signaling pathways relevant to neurodevelopmental and neuropathologic events makes Fyn a long-standing subject of research interest.

Purpose of the Study:

  • To review emerging evidence on the role of Fyn in the pathogenesis of neonatal hypoxic-ischaemic encephalopathy (HIE).
  • To provide a reference for developing novel therapeutic strategies to improve HIE outcomes.
  • To explore additional Fyn-mediated molecular mechanisms contributing to HIE pathology.

Main Methods:

  • This review synthesizes preclinical data and existing literature.
  • It focuses on the signaling pathways regulated by Fyn.
  • The review examines Fyn's involvement in glutamate excitotoxicity, neuroinflammation, and oxidative stress-induced neuronal death.

Main Results:

  • Preclinical data suggest Fyn is a significant factor in HIE pathophysiology.
  • Fyn signaling pathways are implicated in controlling glutamate excitotoxicity.
  • Fyn may promote neuroinflammation and neuronal death via oxidative stress.

Conclusions:

  • Fyn kinase is a critical mediator in the development of neonatal HIE.
  • Targeting Fyn-related pathways offers potential for new HIE treatment strategies.
  • Further research into Fyn's molecular mechanisms in HIE is warranted to improve patient prognosis.